Company / PP&E per Share
RAPT Therapeutics, Inc. PP&E per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.03
FY2024
5-year range
$0.03 / $0.12
FY2020-FY2024
Trend
-47.5%
vs FY2023
Sector context
#134 of 194
Health Care
What the data says
At $0.03, RAPT Therapeutics, Inc.'s pp&e per share ranks #134 of 194 in the Health Care sector. PP&E per Share has declined for 6 consecutive years, from $6.68 in FY2018 to $0.03 in FY2024.
Based on SEC 10-K filings.
0.03 in FY2024 with a 5-year CAGR of -47.6%.
Declined from $0.08 to $0.03 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -30.5%
- 5-Year CAGR
- -47.6%
- 10-Year CAGR
- -
Sector benchmark
#134 of 194 in Health CareTop 69% of 194This company $0.03 Sector average $23.91
▼
-99.9% below sector average
Key checks
Key Insights
- RAPT Therapeutics, Inc.'s pp&e per share has declined for 6 consecutive years.
- In FY2024, pp&e per share decreased 47.5% year-over-year.
- Ranks #134 out of 194 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.38 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.03 | -47.5% |
| FY2023 | $0.06 | -18.2% |
| FY2022 | $0.08 | -22.0% |
| FY2021 | $0.10 | -19.0% |
| FY2020 | $0.12 | -85.5% |
| FY2019 | $0.85 | -87.2% |
| FY2018 | $6.68 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026